Treatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher Disease

This treatment has been approved for sale to the public.

Study NCT00954460 Information provided by Shire Human Genetic Therapies, Inc.

First Received: August 5, 2009 Last Updated: August 4, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This treatment has been approved for sale to the public.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given